SHOP CANNABIS

About CBG:THC 10:20 Advanced Formula

A Blended strain product produced in Ontario by MediPharm Labs using CO2 extraction, in the Cannabis Extracts, Bottled Oils category with 20% Medium THC potency and 10% Moderate CBG content.

Using available terpene and strain data, we find CBG:THC 10:20 Advanced Formula to have a 2/10 score for aid with Inflammation**, including help with Infection, and overall Product Score (ePS) of 6/10 when compared to products in the same category.

Highs include: Added THC content for category; Includes CBG; Strong brand rating. Noted observations: No product specific reviews available.

About MediPharm Labs

A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.

Founded in 2015, MediPharm Labs Corp. is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification.